In the timeline of cancer cachexia, bone loss comes first. Before the weight drops rapidly, bones are already being dismantled — and almost nobody is watching for it at that stage.
Bone is a living tissue that is constantly remodeling. Osteoblasts build new bone, osteoclasts break old bone down. And it is cachexia that tips this balance severely toward breakdown. Inflammatory cytokines, particularly IL-6 and TNF-alpha, directly stimulate osteoclast activity while suppressing osteoblast function. GDF-15 plays a very specific role here increasing osteoclast differentiation and reducing bone formation simultaneously.
The result is an accelerated bone loss that precedes and predicts the muscle and fat wasting that follows. Structurally, this creates fragility fracture risk, pain, and reduced mobility all of which then accelerate inactivity, which accelerates muscle loss, completing another destructive loop.
The clinical implication is important. Bone density monitoring and bone-protective strategies should not wait until cachexia is advanced. Early intervention with bisphosphonates, vitamin D, weight-bearing exercise, and calcium can slow bone loss before it compounds into the broader wasting syndrome.
The skeleton is sounding the alarm before any other tissue. Follow the series, because we have one final organ left that interplays in the cachexia loop.
